Related Experiment Video
Updated: May 28, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
A Friend or Foe: Understanding the Physiological Significance, Therapeutic Uses, and Potential Risks of
Siyi Chen1, Takeshi Ohkubo2, Noriyuki Yanaka1
1Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8528, Japan.
Abstract:
Glycerophosphocholine (GPC) is a well-known choline-containing compound commonly found in nature and has demonstrated potential therapeutic effects in aging-related conditions, such as neurodegenerative disorders, skeletal muscle performance, and eye disorders. Despite being widely used as a supplement, the mechanism by which GPC is absorbed and metabolized in the digestive system remains elusive. Furthermore, growing evidence suggests that high intake of choline-containing compounds, including GPC, is linked with trimethylamine N-oxide (TMAO) production, a metabolite associated with atherosclerosis progression. However, there has been an inconsistency that is not commonly discussed, and thus, the adverse effect of TMAO remains debatable. These warrant a better understanding of the physiological significance and metabolism of GPC in the body and how it is linked to TMAO and its potential risk. Through a comprehensive literature search, this narrative review aims to fill these gaps by providing a summary of the physiological significance and supplementation evidence of GPC. Further, the review also highlights the absorption mechanisms and relationship of GPC with intestinal microbiota and its relationship with TMAO production. Lastly, this review addresses and discusses the challenge of GPC supplementation and provides a brief view on future perspectives on GPC as a bioactive compound.
Related Concept Videos
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Parasympathetic Signaling
The effects of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
